The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre

Gut

Volumn 44, Issue 4, 1999, Pages 563-567

  Datz, C ^a   Cramp, M ^d   Haas, T ^a   Dietze, O ^b   Nitschko, H ^e   Froesner, G ^e   Muss, N ^a   Sandhofer, F ^a   Vogel, W ^c  

^a First Dept of Internal Medicine   (Austria)

^b University of Innsbruck ^*  (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Disease progression; Hepatitis C; Natural course; Non A, non B hepatitis; Plasmapheresis

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS DETECTION;

EID: 0032931159     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.4.563     Document Type: Article

References (34)

1. Van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-9.
2. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
3. Alter MJ, Margolis HS, Krawezynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992;32:1899-905.
4. Cory-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus liver infection. N Engl J Med 1996;344:1691-6.
5. Di Bisceglie AM, Goodman ZD, Ishak KG, et al. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991;14:969-74.
6. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Natural history of liver progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
7. Seef LB, Buskell-Bales Z, Wright EC, et al, and the National Heart, Lung and Blood Institute study group. Long-term mortality after transfusion associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-11.
8. Tremolada F, Casarin C, Alberti A, et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992;16:273-81.
9. Tong MJ, El-Farra NS, Reikes AR, et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-6.
10. Takahashi M, Yamada G, Miyamoto R, et al. Natural course of chronic hepatitis C. Am J Gastroenterol 1993;88:240-3.
11. Crowe J, Doyle C, Fielding JF, et al. Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation [abstract]. Gastroenterology 1995;108:A1054.
12. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 1995;15:64-9.
13. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
14. Tong MJ, el Farra NS. Clinical sequelae of hepatitis C aquired from injection drug use. West J Med 1996;164:399-404.
15. Dusheiko G, Schmilovitz Weiss H, Brown D, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994;19:13-18.
16. Gretch D, Corey I, Wilson J, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis 1994;169:1219-25.
17. Kato N, Yokosuka O, Hosoda K, et al. Quantification of hepatitis C virus by competitive reverse transcription polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993;18:16-20.
18. Honda M, Kaneko S, Sakai A, et al. Degree of diversity of hepatitis C quasispecies and progression of liver disease. Hepatology 1994;20:1148-51.
19. Farci P, Melpolder JC, Shimolda A, et al. Studies of HCV quasispecies in patients with acute resolving hepatitis compared with those who progress to chronic hepatitis. Hepatology 1996;24:350A.
20. Kobayashi M, Tanaka E, Sodeyama T, et al. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996;23:695-9.
21. Liaw Y-F. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995;22:1101-8.
22. Telfer P, Sabin C, Devereux H, et al. the progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 1994;87:555-61.
23. Muss N, Frösner G, Sandhofer F. Epidemic outbreak of a non-a, non-B hepatitis in a plasmapheresis center. Epidemiological observations. Infection 1985;2:57-60.
24. Simmonds P, McOmish F, Yap PL, et al. Sequence variability in the 5′ non-coding region of hepatitis C virus. Identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993;74:661-8.
25. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
26. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19:1321-4.
27. Dittmann S, Roggendorf M, Dürkop J, et al. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991;13:323-7.
28. Oshita M, Hayashi N, Kasahara A, et al. Increased serum hepatitis C virus levels among alcoholic patients with chronic hepatitis C. Hepatology 1994;20:1015-20.
29. Noda K, Yoshihara H, Suzuki K, et al. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma - its relationship to alcohol drinking and the age of transfusion. Alcohol Exp Res 1996;20(suppl):95-100A.
30. Di Bisceglie AM. Hepatitis C. Lancet 1998;351:351-6.
31. Pederson C, Linhardt PO, Jensen BL, et al. Clincal course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989;299:154-7.
32. Tindall B, Cooper DA. Primary HIV infection: host responses and intervention strategies. AIDS 1991;5:1-14.
33. Cramp ME, Carucci P, Donaldson PT, et al. HLA class II alleles and spontaneous clearance of hepatitis C virus [abstract]. J Hepatol 1997;26:81.
34. Zavaglia C, Martinetti M, Silini E, et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 1998;28:1-7.